LIPOPROTEIN(A)
Clinical trials for LIPOPROTEIN(A) explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN(A) trials appear
Sign up with your email to follow new studies for LIPOPROTEIN(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to tackle stubborn heart risk factor
Disease control Not yet recruitingThis Phase 2 trial tests an experimental drug called MK-7262, alone or with another drug called enlicitide, in 750 adults with high levels of lipoprotein(a) – a genetic risk factor for heart disease. The study compares these drugs to a placebo to see if they can safely lower both…
Matched conditions: LIPOPROTEIN(A)
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Digital nudge: could a letter save your heart?
Knowledge-focused Not yet recruitingThis study tests whether sending an electronic letter to people with heart disease and high cholesterol encourages them to get their cholesterol checked. Researchers will compare those who receive the letter to those who don't, using national health records to track results. The …
Matched conditions: LIPOPROTEIN(A)
Phase: NA • Sponsor: Tor Biering-Sørensen • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC